These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 9923963
1. Increased uridine kinase (ATP: uridine 5'-phosphotransferase; EC 2.7.1.48) activity in human and rat tumors. Shen F, Look KY, Yeh YA, Weber G. Cancer Biochem Biophys; 1998 Jun; 16(1-2):1-15. PubMed ID: 9923963 [Abstract] [Full Text] [Related]
2. 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction enzyme. Singhal RL, Prajda N, Yeh YA, Weber G. Cancer Res; 1994 Nov 01; 54(21):5574-8. PubMed ID: 7923199 [Abstract] [Full Text] [Related]
4. Phospholipase C (EC 3.1.4.11): a malignancy linked signal transduction enzyme. Yang H, Shen F, Herenyiova M, Weber G. Anticancer Res; 1998 Nov 01; 18(3A):1399-404. PubMed ID: 9673347 [Abstract] [Full Text] [Related]
5. Proliferation-linked increase in phosphoribosylformylglycinamidine synthetase activity (EC 6.3.5.3). Elliott WL, Weber G. Cancer Res; 1984 Jun 01; 44(6):2430-4. PubMed ID: 6722784 [Abstract] [Full Text] [Related]
6. Increased 5-phospho-alpha-D-ribose-1-diphosphate synthetase (ribosephosphate pyrophosphokinase, EC 2.7.6.1) activity in rat hepatomas. Baló-Banga JM, Weber G. Cancer Res; 1984 Nov 01; 44(11):5004-9. PubMed ID: 6091867 [Abstract] [Full Text] [Related]
7. Increased signal transduction activity and down-regulation in human cancer cells. Weber G, Shen F, Prajda N, Yeh YA, Yang H, Herenyiova M, Look KY. Anticancer Res; 1996 Nov 01; 16(6A):3271-82. PubMed ID: 9042300 [Abstract] [Full Text] [Related]
8. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver. Heinrich PC, Morris HP, Weber G. Cancer Res; 1976 Sep 01; 36(9 pt.1):3189-97. PubMed ID: 10080 [Abstract] [Full Text] [Related]
9. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues. Natsumeda Y, Prajda N, Donohue JP, Glover JL, Weber G. Cancer Res; 1984 Jun 01; 44(6):2475-9. PubMed ID: 6327016 [Abstract] [Full Text] [Related]
10. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2). Prajda N, Morris HP, Weber G. Cancer Res; 1976 Dec 01; 36(12):4639-46. PubMed ID: 187329 [Abstract] [Full Text] [Related]
11. Increased carbamoyl-phosphate synthetase II concentration in rat hepatomas: immunological evidence. Reardon MA, Weber G. Cancer Res; 1985 Sep 01; 45(9):4412-5. PubMed ID: 4028025 [Abstract] [Full Text] [Related]
12. [Isolation and properties or uridine kinase from Zajdela hepatoma cells]. Dubinina IG, Shkurko VG, Vornovitskaia GI. Biokhimiia; 1981 Oct 01; 46(10):1905-16. PubMed ID: 6272884 [Abstract] [Full Text] [Related]
13. Increased thymidylate synthase (EC 2.1.1.45) activity in normal and neoplastic proliferation. Hashimoto Y, Shiotani T, Eble JN, Glover JL, Weber G. Cancer Biochem Biophys; 1988 Jul 01; 10(1):1-10. PubMed ID: 3224329 [Abstract] [Full Text] [Related]
14. Regulation of signal transduction. Weber G, Singhal RL, Prajda N, Yeh YA, Look KY, Sledge GW. Adv Enzyme Regul; 1995 Jul 01; 35():1-21. PubMed ID: 7572337 [Abstract] [Full Text] [Related]
15. Activities of some enzymes of pyrimidine and DNA synthesis in a rat transplantable hepatoma and human primary hepatomas, in cell lines derived from these tissues, and in human fetal liver. Cummins RR, Balinsky D. Cancer Res; 1980 Apr 01; 40(4):1235-9. PubMed ID: 6244089 [Abstract] [Full Text] [Related]
20. Decreased concentration of xanthine dehydrogenase (EC 1.1.1.204) in rat hepatomas. Ikegami T, Natsumeda Y, Weber G. Cancer Res; 1986 Aug 01; 46(8):3838-41. PubMed ID: 3460692 [Abstract] [Full Text] [Related] Page: [Next] [New Search]